Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Apple avoids $300m payout as court orders new trial in LTE patent case against Optis Apple wins key reversal in $300M LTE patent case as court demands new trial over jury flaws. Discover what this means for FRAND enforcement going forward. byPallavi MadhirajuJune 19, 2025